Effects	O
of	O
Smoke	B:C0037366
Generated	O
by	O
Electrocautery	O
on	O
the	O
Larynx	O

Effects	O
of	O
Smoke	O
Generated	O
by	O
Electrocautery	O
on	O
the	O
Larynx	B:C0023078

The	O
aim	O
of	O
this	O
study	B:C0008972
was	O
to	O
investigate	O
effects	O
of	O
smoke	O
produced	O
by	O
electrocautery	O
on	O
the	O
laryngeal	O
mucosa	I:C0023053
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	B:C0220825
effects	O
of	O
smoke	O
produced	O
by	O
electrocautery	O
on	O
the	O
laryngeal	O
mucosa	I:C0023053
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
effects	O
of	O
smoke	B:C0037366
produced	O
by	O
electrocautery	O
on	O
the	O
laryngeal	O
mucosa	I:C0023053
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
effects	O
of	O
smoke	O
produced	O
by	O
electrocautery	O
on	O
the	O
laryngeal	B:C0023053
mucosa	I:C0023053
.	O

We	O
divided	O
the	O
rats	B:C0086893
into	O
two	O
groups	O
.	O

Eight	O
rats	B:C0086893
were	O
exposed	O
to	O
smoke	O
for	O
60	O
min/d	O
for	O
4	O
weeks	O
,	O
and	O
eight	O
rats	O
were	O
not	O
exposed	O
to	O
smoke	O
and	O
served	O
as	O
controls	O
.	O

Eight	O
rats	O
were	O
exposed	O
to	O
smoke	B:C0037366
for	O
60	O
min/d	O
for	O
4	O
weeks	O
,	O
and	O
eight	O
rats	O
were	O
not	O
exposed	O
to	O
smoke	O
and	O
served	O
as	O
controls	O
.	O

Eight	O
rats	O
were	O
exposed	O
to	O
smoke	O
for	O
60	O
min/d	O
for	O
4	O
weeks	O
,	O
and	O
eight	O
rats	B:C0086893
were	O
not	O
exposed	O
to	O
smoke	O
and	O
served	O
as	O
controls	O
.	O

Eight	O
rats	O
were	O
exposed	O
to	O
smoke	O
for	O
60	O
min/d	O
for	O
4	O
weeks	O
,	O
and	O
eight	O
rats	O
were	O
not	O
exposed	O
to	O
smoke	B:C0037366
and	O
served	O
as	O
controls	O
.	O

The	O
experimental	O
group	O
was	O
maintained	O
in	O
a	O
plexiglass	B:C0600424
cabin	O
during	O
exposure	O
to	O
smoke	O
.	O

The	O
experimental	O
group	O
was	O
maintained	O
in	O
a	O
plexiglass	O
cabin	O
during	O
exposure	O
to	O
smoke	B:C0037366
.	O

At	O
the	O
end	O
of	O
4	O
weeks	O
,	O
rats	B:C0086893
were	O
sacrificed	O
under	O
high	O
-	O
dose	O
ketamine	O
anesthesia	O
.	O

At	O
the	O
end	O
of	O
4	O
weeks	O
,	O
rats	O
were	O
sacrificed	O
under	O
high	O
-	O
dose	O
ketamine	B:C0022614
anesthesia	O
.	O

At	O
the	O
end	O
of	O
4	O
weeks	O
,	O
rats	O
were	O
sacrificed	O
under	O
high	O
-	O
dose	O
ketamine	O
anesthesia	B:C4049933
.	O

Each	O
vocal	B:C0042930
fold	I:C0042930
was	O
removed	O
.	O

An	O
expert	B:C0334901
pathologist	I:C0334901
blinded	O
to	O
the	O
experimental	O
group	O
evaluated	O
the	O
tissues	O
for	O
the	O
following	O
:	O
epithelial	O
distribution	O
,	O
inflammation	O
,	O
hyperplasia	O
,	O
and	O
metaplasia	O
.	O

An	O
expert	O
pathologist	I:C0334901
blinded	O
to	O
the	O
experimental	O
group	O
evaluated	B:C0220825
the	O
tissues	O
for	O
the	O
following	O
:	O
epithelial	O
distribution	O
,	O
inflammation	O
,	O
hyperplasia	O
,	O
and	O
metaplasia	O
.	O

An	O
expert	O
pathologist	I:C0334901
blinded	O
to	O
the	O
experimental	O
group	O
evaluated	O
the	O
tissues	B:C0040300
for	O
the	O
following	O
:	O
epithelial	O
distribution	O
,	O
inflammation	O
,	O
hyperplasia	O
,	O
and	O
metaplasia	O
.	O

An	O
expert	O
pathologist	I:C0334901
blinded	O
to	O
the	O
experimental	O
group	O
evaluated	O
the	O
tissues	O
for	O
the	O
following	O
:	O
epithelial	B:C0014609
distribution	O
,	O
inflammation	O
,	O
hyperplasia	O
,	O
and	O
metaplasia	O
.	O

An	O
expert	O
pathologist	I:C0334901
blinded	O
to	O
the	O
experimental	O
group	O
evaluated	O
the	O
tissues	O
for	O
the	O
following	O
:	O
epithelial	O
distribution	O
,	O
inflammation	B:C0021368
,	O
hyperplasia	O
,	O
and	O
metaplasia	O
.	O

An	O
expert	O
pathologist	I:C0334901
blinded	O
to	O
the	O
experimental	O
group	O
evaluated	O
the	O
tissues	O
for	O
the	O
following	O
:	O
epithelial	O
distribution	O
,	O
inflammation	O
,	O
hyperplasia	B:C0020507
,	O
and	O
metaplasia	O
.	O

An	O
expert	O
pathologist	I:C0334901
blinded	O
to	O
the	O
experimental	O
group	O
evaluated	O
the	O
tissues	O
for	O
the	O
following	O
:	O
epithelial	O
distribution	O
,	O
inflammation	O
,	O
hyperplasia	O
,	O
and	O
metaplasia	B:C0025568
.	O

Mucosal	B:C0026724
cellular	O
activities	I:C0007613
were	O
assessed	O
by	O
immunohistochemical	O
staining	I:C4055454
for	I:C4055454
Ki67	I:C4055454
.	O

Mucosal	O
cellular	B:C0007613
activities	I:C0007613
were	O
assessed	O
by	O
immunohistochemical	O
staining	I:C4055454
for	I:C4055454
Ki67	I:C4055454
.	O

Mucosal	O
cellular	O
activities	I:C0007613
were	O
assessed	O
by	O
immunohistochemical	B:C4055454
staining	I:C4055454
for	I:C4055454
Ki67	I:C4055454
.	O

Results	O
taken	O
before	O
and	O
after	O
effect	O
were	O
compared	O
statistically	B:C0038208
.	O

There	O
was	O
a	O
significant	O
difference	O
in	O
the	O
extent	B:C0439792
of	O
inflammation	O
between	O
the	O
experimental	O
group	O
and	O
the	O
control	O
group	O
.	O

There	O
was	O
a	O
significant	O
difference	O
in	O
the	O
extent	O
of	O
inflammation	B:C0021368
between	O
the	O
experimental	O
group	O
and	O
the	O
control	O
group	O
.	O

Squamous	B:C0025570
metaplasia	I:C0025570
was	O
detected	O
in	O
each	O
group	O
,	O
but	O
the	O
difference	O
was	O
not	O
significant	I:C1273937
.	O

Squamous	O
metaplasia	I:C0025570
was	O
detected	B:C0442726
in	O
each	O
group	O
,	O
but	O
the	O
difference	O
was	O
not	O
significant	I:C1273937
.	O

Squamous	O
metaplasia	I:C0025570
was	O
detected	O
in	O
each	O
group	O
,	O
but	O
the	O
difference	O
was	O
not	B:C1273937
significant	I:C1273937
.	O

None	O
of	O
the	O
larynges	B:C0023078
in	O
either	O
group	O
developed	O
hyperplasia	O
.	O

None	O
of	O
the	O
larynges	O
in	O
either	O
group	O
developed	O
hyperplasia	B:C0020507
.	O

We	O
showed	O
increased	O
tissue	B:C0040300
inflammation	O
due	O
to	O
irritation	O
by	O
the	O
smoke	O
.	O

We	O
showed	O
increased	O
tissue	O
inflammation	B:C0021368
due	O
to	O
irritation	O
by	O
the	O
smoke	O
.	O

We	O
showed	O
increased	O
tissue	O
inflammation	O
due	O
to	O
irritation	B:C1706307
by	O
the	O
smoke	O
.	O

We	O
showed	O
increased	O
tissue	O
inflammation	O
due	O
to	O
irritation	O
by	O
the	O
smoke	B:C0037366
.	O

